RecruitingNot ApplicableNCT05397197

Impact of Moderate Preterm Birth on Vocabulary Acquisition

A Longitudinal Study of the Impact of Moderate Preterm Birth on Cortical and Subcortical Processing of Speech Sounds and Vocabulary Acquisition


Sponsor

Assistance Publique Hopitaux De Marseille

Enrollment

160 participants

Start Date

Oct 19, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Children born prematurely may present a neurodevelopmental disorder with a language delay diagnosed as early as 2-3 years of age. This situation is not uncommon: each year in France, approximately 35,000 children are born between 32 and 36 weeks of amenorrhea. In our most recent work, we have shown that moderate premature infants show an attenuated cortical response to a vowel change, suggesting a deficit in the cortical encoding of vowels. This work needs to be continued in order to better understand syllable encoding and identify the neuroplasticity mechanisms underlying early speech encoding. The identification of markers to predict language development is essential for the screening of these children at risk of language delay. These children could thus benefit from early adapted care even before the appearance of language deficits.


Eligibility

Min Age: 0 DaysMax Age: 2 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Electroencephalography for people with premature birth. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERElectroencephalography

experimental task, neuropsychological evaluation, clinical exam


Locations(1)

Service de Neuropédiatrie

Marseille, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05397197


Related Trials